Ublituximab and umbralisib in relapsed/refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Lunning M, Vose J, Nastoupil L, Fowler N, Burger JA, Wierda WG, Schreeder MT, Siddiqi T, Flowers CR, Cohen JB, Sportelli P, Miskin HP, Weiss MS, O'Brien S.
Lunning M, et al.
Blood. 2019 Nov 21;134(21):1811-1820. doi: 10.1182/blood.2019002118.
Blood. 2019.
PMID: 31558467
Free PMC article.
Clinical Trial.